Sentence examples for decreased adverse from inspiring English sources
These results taken together could provide impetus for rational design and optimization of more selective and high affinity leads with a potential to have decreased adverse effects.
Insurance providers may be willing to support continuously monitoring of all patients on opioids because it has been proven to save money in terms of shorter hospital stays, less ICU transfers and decreased adverse patient events.
The Coalition has shown that when a hospital invests in technology to continuously monitor patients on opioids, it results in decreased adverse patient outcomes, decreased ICU transfers, decreased lengths of stays – and overall, lower costs.
Lighter sedation strategies in a lower nursing staff level ICU may expose patients on mechanical ventilation to care-associated risks, such as accidental extubation, since there is a trend between increased nurse staffing levels and decreased adverse patient outcomes in ICU [11].
Including a pharmacist in the interdisciplinary team is linked to decreased adverse drug events and cost of care [ 17].
TENS improved incontinence symptoms, enhanced the quality of life, and decreased adverse effects; hence, it is recommended in treating poststroke UI.
Left atrial catecholamine administration is effective in decreasing pulmonary arterial drug concentrations and may decrease adverse pulmonary effects in clinical practice.
Biomedical models of health care decrease adverse consequences of disease, but are not enough to effectively improve individual and population health and advance health equity.
Moreover, there is an increasing need for controlling the delivery in relation to both dose and site, in order to decrease adverse side effects.
The in vivo therapeutic studies in MCF-7 human breast tumor-bearing nude mice show that DOX-CLNPs effectively inhibit tumor growth, improve survival rate, and significantly decrease adverse effects as compared to DOX-LPs.
An immediate-release, multiparticulate capsule formulation of tizanidine has been developed to modify tizanidine pharmacokinetic characteristics in an attempt to decrease adverse events (AEs) while maintaining effectiveness in the management of spasticity.
